GERDES; Christian
Patent Applications and Registrations
Patent applications and USPTO patent grants for GERDES; Christian.The latest application filed is for "antibodies for chelated radionuclides and clearing agents".
- GERDES; Christian - Buenos Aires AR
- GERDES; Christian - Erlenbach CH
- GERDES; Christian - Erlenbach/ZH CH
| Patent | Date |
|---|---|
| Antibodies For Chelated Radionuclides And Clearing Agents App 20220031871 - TORGUE; Julien ; et al. | 2022-02-03 |
| Combination Il-2 Immunoconjugate Therapy App 20200197492 - GERDES; Christian ; et al. | 2020-06-25 |
| Combination IL-2 immunoconjugate therapy Grant 10,603,360 - Gerdes , et al. | 2020-03-31 |
| Combination Therapy Of Antibodies Activating Human Cd40 And Antibodies Against Human Pd-l1 App 20200095313 - CORSE; Emily Rana ; et al. | 2020-03-26 |
| Combination Therapy Of Antibodies Activating Human Cd40 And Antibodies Against Human Pd-l1 App 20180051077 - Corse; Emily Rana ; et al. | 2018-02-22 |
| Combination Il-2 Immunoconjugate Therapy App 20170056522 - Gerdes; Christian ; et al. | 2017-03-02 |
| Combination IL-2 immunoconjugate therapy Grant 9,526,797 - Gerdes , et al. December 27, 2 | 2016-12-27 |
| Combination Therapy Of Anti-her3 Antibodies App 20160159912 - Bauss; Frieder ; et al. | 2016-06-09 |
| Predictive biomarker for cancer treatment with ADCC-enhanced antibodies Grant 9,360,481 - Di Scala , et al. June 7, 2 | 2016-06-07 |
| In Vivo Adcc Model App 20160058891 - Breustedt; Daniel ; et al. | 2016-03-03 |
| Combination Therapy Of Antibodies Activating Human Cd40 And Antibodies Against Human Pd-l1 App 20160045597 - CORSE; Emily Rana ; et al. | 2016-02-18 |
| Combination therapy of anti-HER3 antibodies Grant 9,180,185 - Bauss , et al. November 10, 2 | 2015-11-10 |
| Combination Therapy Of Anti-her3 Antibodies App 20140227255 - Bauss; Frieder ; et al. | 2014-08-14 |
| Predictive biomarker for cancer treatment with ADCC-enhanced antibodies App 20140227256 - Di Scala; Lilla ; et al. | 2014-08-14 |
| Immunotherapy App 20140072528 - Gerdes; Christian ; et al. | 2014-03-13 |
| Immunotherapy App 20140065097 - Gerdes; Christian ; et al. | 2014-03-06 |
| Predictive Biomarker For Cancer Treatment With Adcc-enhanced Antibodies App 20130273032 - Gerdes; Christian ; et al. | 2013-10-17 |
| Predictive Biomarker For Cancer Treatment With Adcc-enhanced Antibodies App 20130195854 - Gerdes; Christian ; et al. | 2013-08-01 |
| Immunotherapy App 20120258073 - Gerdes; Christian ; et al. | 2012-10-11 |
| Bispecific Anti-egfr/anti-igf-1r Antibodies App 20120149879 - Brinkmann; Ulrich ; et al. | 2012-06-14 |
| TREATMENT WITH A HUMANIZED IgG CLASS ANTI EGFR ANTIBODY AND AN ANTIBODY AGAINST INSULIN LIKE GROWTH FACTOR 1 RECEPTOR App 20110200595 - Gerdes; Christian ; et al. | 2011-08-18 |
| Bispecific Anti-egfr/anti-igf-1r Antibodies App 20100081796 - Brinkmann; Ulrich ; et al. | 2010-04-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 